Diseases and Disorders

39
Diseases and Disorders is an Android app from Unbound Medicine, Inc, currently rated 3.2★ across 21 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 39: Emerging (early traction worth watching). For an app like this, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 🌐 Cross-platform reach (iOS + Android) | +$27K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating < 3.5 (weak) | -18% |
| ⭐ Small user base (<1K ratings) | -8% |
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
| 🏷 Category context | category |
| 📦 Compact Android bundle | → Native Kotlin |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Pre-traction · 38/100INDIE TIERlimited signal- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 3.2★ across 21 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Moderate — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Below-average rating (3.2★)METRIC | −$1,500 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Pre-traction phase (21 ratings)METRIC | −$300 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- Diseases and Disorders
- Developer
- Unbound Medicine, Inc
- Bundle ID
- com.unbound.android.cqt3l
- App Store URL
- Not found
- Category
- Not found
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- Not found
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Reported revenue signal / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- Model estimate / mo
- $500/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
FREE PREVIEW – View select topics to see how this evidence-based resource can help you save time in finding disease and disorder details.
ABOUT DISEASES AND DISORDERS
Diseases & Disorders is a must-have reference for every nurse and nursing student. With complete coverage of more than 240 medical conditions encountered in nursing practice, you can quickly access the information you need to effectively plan and deliver patient care.… View full description on the official store →
Track this app’s revenue
FREE📝 Description
95
More by Unbound Medicine, Inc
View all →Why low confidence: only 21 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
Diseases and Disorders is a small / niche Android app with weak public traction — only 21 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.



